Publication date: Sep 01, 2024
COVID-19 as an infectious disease with rapid transmission speed is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), so, early and accurate diagnostics of COVID-19 is quite challenging. In this work, the selective and sensitive self-enhanced ECL method to detect of SARS-CoV-2 protein was designed with magnetic N-doped carbon derived from dual-ligand metal-organic frameworks (MOF) (CoO@N-C) with the primary and tertiary amino groups as a novel coreactant that covalently combined with Ru(bpy)(phen-NH) as electrochemiluminescence (ECL) emitter. Mixed-ligand strategy and selected nitrogen-containing ligands, 4,4′,4”-((1,3,5-triazine-2,4,6-triyl) tris-(azanediyl)) tribenzoic acid (HTATAB) with 2-aminoterephthalic acid (BDC-NH) were used for synthesis of the proposed MOF. Also, magnetic CoO@N-C with high synergistically charge transfer kinetics and good stability can be used as an effective platform/coreactor on the ITO electrode which load more Ru-complex as signal producing compound and SARS-CoV-2 N protein antibody to increase the sensitivity of the immunosensor. Furthermore, (CoO@N-C) as coreactor improved the ECL signal of the Ru (II)-complex more than 2. 1 folds compared to tripropylamine. In view of these competences, the novel “on-off” ECL biosensor performed with great stability and repeatability for detection of SARS-CoV-2 protein, which exhibited a broad linearity from 8 fg. mL to 4 ng. mL (6 order of magnitude) and an ultra-low limit of detection 1. 6 fg. mL. Finally, this proposed method was successfully applied to detect of SARS-CoV-2 N protein in serum sample with satisfactory results, indicating the proposed immunosensor has the potential for quick analysis of SARS-CoV-2.
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Activated charcoal |
disease | VO | effective |
disease | MESH | COVID-19 |
disease | MESH | infectious disease |
pathway | REACTOME | Infectious disease |
disease | VO | Severe acute respiratory syndrome coronavirus 2 |
disease | VO | SARS-CoV-2 protein |
drug | DRUGBANK | Nitrogen |
drug | DRUGBANK | Tromethamine |